Bridgeworth, LLC Abb Vie Inc. Transaction History

Bridgeworth, LLC

$1.01 Billion
Q4 2023

A detailed history of Bridgeworth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bridgeworth, LLC holds 5,454 shares of ABBV stock, worth $955,377. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,454

Previous 5,504 0.91%

Holding current value

$955,377

Previous $820,000 3.05%

% of portfolio

0.08%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $6,880 - $7,748	-50 Reduced 0.91%	5,454 $845,000
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $10,954 - $12,681	-82 Reduced 1.47%	5,504 $820,000
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $45,318 - $56,395	-342 Reduced 5.77%	5,586 $752,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $51,625 - $59,454	-357 Reduced 5.68%	5,928 $944,000
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $24,292 - $27,861	-181 Reduced 2.8%	6,285 $844,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $2,752 - $3,499	-20 Reduced 0.31%	6,466 $990,000
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $110,599 - $137,222	-838 Reduced 11.44%	6,486 $1.05 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $160,392 - $202,943	1,493 Added 25.6%	7,324 $992,000
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $9,788 - $11,111	-92 Reduced 1.55%	5,831 $629,000
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $28,091 - $31,295	-267 Reduced 4.31%	5,923 $667,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $30,076 - $33,110	-294 Reduced 4.53%	6,190 $670,000
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $95,944 - $129,534	1,192 Added 22.52%	6,484 $695,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $45,360 - $53,238	-528 Reduced 9.07%	5,292 $464,000
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $14,674 - $19,636	-200 Reduced 3.32%	5,820 $571,000
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $1,032 - $1,564	-16 Reduced 0.27%	6,020 $459,000
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $28,202 - $35,287	-391 Reduced 6.08%	6,036 $534,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $41,755 - $50,202	663 Added 11.5%	6,427 $487,000
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $15,833 - $20,239	241 Added 4.36%	5,764 $419,000
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $173,179 - $203,823	-2,245 Reduced 28.9%	5,523 $445,000
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $1,089 - $1,344	-14 Reduced 0.18%	7,768 $599,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $86,064 - $95,677	968 Added 14.21%	7,782 $620,000
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $93,640 - $110,797	-1,043 Reduced 13.27%	6,814 $631,000
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $722,922 - $968,060	7,857 New	7,857 $716,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeworth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeworth, LLC with notifications on news.

Account